购物车
- 全部删除
- 您的购物车当前为空
Anti-TCERG1L Antibody (2I293) 是一种 Mouse 抗体,靶向 TCERG1L。Anti-TCERG1L Antibody (2I293) 可用于 IHC-P。
Anti-TCERG1L Antibody (2I293) 是一种 Mouse 抗体,靶向 TCERG1L。Anti-TCERG1L Antibody (2I293) 可用于 IHC-P。
产品描述 | Anti-TCERG1L Antibody (2I293) is a Mouse antibody targeting TCERG1L. Anti-TCERG1L Antibody (2I293) can be used in IHC-P. |
Ig Type | Monoclonal Mouse IgG1 |
克隆号 | 2I293 |
交叉反应 | Human |
验证活性 | Immunochemical staining of human TCERG1L in human pancreas with mouse monoclonal antibody (1:500, formalin-fixed paraffin embedded sections). |
应用 | IHC-P |
推荐剂量 | IHC-P: 1:250-1:1000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with a synthetic peptide corresponding to the C-terminus of the Human TCERG1L. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | Transcription elongation regulator 1-like (TCERG1L) gene is located in chromosome 10. TCERG1L gene may have similar biological role with TCERG1 (transcription elongation regulator 1), located on human chromosome 5q32. TCERG1 (also known as TAF2S; TATA box-binding protein-associated factor 2S, CA150; transcription factor CA150) was first described as a transcriptional elongation regulator found in human immunodeficiency virus type 1 (HIV-1), tat-responsive HeLa nuclear fractions. TCERG1L gene has been reported to be highly frequently methylated in colon tumors and was selected as a candidate for the early detection of biomarkers for colon cancer patients. |
偶联 | Unconjugated |
免疫原 | A synthetic peptide corresponding to the C-terminus of the Human TCERG1L |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容